Sarinrat Wonglee
Sarinrat Wonglee has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Piyanud Thongjerm
Nuclear Technology Research and Development Center, Thailand Institute of Nuclear Technology, Nakhon Nayok, Thailand
3 shared publications - Weerawat Pornroongruengchok
Nuclear Technology Research and Development Center, Thailand Institute of Nuclear Technology, Nakhon Nayok, Thailand
3 shared publications - Adisorn Phaepilin
Ecocultural Entrepreneurship Program, Mahidol University, Nakhon Sawan Campus, Nakhon Sawan 60130, Thailand
1 shared publication Adundet Khurasi
Thailand Institute of Nuclear Technology
1 shared publicationAkkapob Ngamlamiad
Thailand Institute of Nuclear Technology
1 shared publication- Atchariya Yosboonruang
Division of Microbiology and Parasitology, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by Taylor & Francis in Journal of Nuclear Science and Technology
- Vol. 63 (11) , 1312-1321
Design and Geant4 simulation of an energy degrader system for PIXE and PIGE at the TINT cyclotron facility
- 30 June 2026
- Published by Taylor & Francis in Journal of Nuclear Science and Technology
- Vol. 63 (11) , 1312-1321
Open AccessDesign and Geant4 simulation of an energy degrader system for PIXE and PIGE at the TINT cyclotron facility
- Open Access
- 6 March 2026
- Published by MDPI AG in Nanomaterials
- Vol. 16 (5) , 334
Microwave-Assisted Biosynthesis of Silver Nanoparticles Using Chlorella sp. for Antibacterial and Cytotoxicity Effects of Breast Cancer Cell Line
Microwave-assisted biosynthesis using marine Chlorella sp. extracts provides a green and efficient route for the production of silver nanoparticles (AgNPs). Compared with the conventional method (24 h), microwave-assisted synthesis reduces the reaction time to less than 7 min while producing smaller and more uniformly distributed nanoparticles. AgNPs were synthesized using extracts obtained with different solvents and directly compared with those produced via the conventional method to substantiate the efficiency of the microwave-assisted approach. UV–visible spectroscopy confirmed rapid nanoparticle formation, exhibiting surface plasmon resonance peaks in the range of 405 to 427 nm. TEM analysis revealed predominantly spherical AgNPs with particle sizes of approximately 10 to 20 nm. The XRD and FTIR analyses confirmed their crystalline structure and stabilization by algal-derived functional groups. The biological activities of the AgNPs were dependent on the extraction solvent. AgNPs synthesized using hexane extracts exhibited pronounced antibacterial activity, achieving minimum inhibitory concentrations as low as 0.31 µg/mL. In addition, the AgNP induced concentration-dependent cytotoxic effects in human breast cancer cell lines. IC50 values, determined via dose–response analysis, ranged from 0.18 to 0.67 μg/mL in MDA-MB-231 cells and 1.70 to 8.42 μg/mL in MCF-7 cells. These results indicate a potent cytotoxic profile, with MDA-MB-231 cells exhibiting significantly higher sensitivity to the microwave-assisted formulations. Collectively, these findings highlight microwave-assisted algal-mediated biosynthesis as a sustainable and effective platform for generating bioactive AgNPs with promising antibacterial and anticancer potential.
- 6 March 2026
- Published by MDPI AG in Nanomaterials
- Vol. 16 (5) , 334
Open AccessMicrowave-Assisted Biosynthesis of Silver Nanoparticles Using Chlorella sp. for Antibacterial and Cytotoxicity Effects of Breast Cancer Cell Line
Microwave-assisted biosynthesis using marine Chlorella sp. extracts provides a green and efficient route for the production of silver nanoparticles (AgNPs). Compared with the conventional method (24 h), microwave-assisted synthesis reduces the reaction time to less than 7 min while producing smaller and more uniformly distributed nanoparticles. AgNPs were synthesized using extracts obtained with different solvents and directly compared with those produced via the conventional method to substantiate the efficiency of the microwave-assisted approach. UV–visible spectroscopy confirmed rapid nanoparticle formation, exhibiting surface plasmon resonance peaks in the range of 405 to 427 nm. TEM analysis revealed predominantly spherical AgNPs with particle sizes of approximately 10 to 20 nm. The XRD and FTIR analyses confirmed their crystalline structure and stabilization by algal-derived functional groups. The biological activities of the AgNPs were dependent on the extraction solvent. AgNPs synthesized using hexane extracts exhibited pronounced antibacterial activity, achieving minimum inhibitory concentrations as low as 0.31 µg/mL. In addition, the AgNP induced concentration-dependent cytotoxic effects in human breast cancer cell lines. IC50 values, determined via dose–response analysis, ranged from 0.18 to 0.67 μg/mL in MDA-MB-231 cells and 1.70 to 8.42 μg/mL in MCF-7 cells. These results indicate a potent cytotoxic profile, with MDA-MB-231 cells exhibiting significantly higher sensitivity to the microwave-assisted formulations. Collectively, these findings highlight microwave-assisted algal-mediated biosynthesis as a sustainable and effective platform for generating bioactive AgNPs with promising antibacterial and anticancer potential.
- Open Access
- 9 July 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (14) , 7670
GEANT4 Simulation of Proton Beam Properties from a Cyclotron Accelerator at King Chulalongkorn Memorial Hospital
The main objective of proton beam therapy is to precisely irradiate diseased tissue while minimizing damage to healthy cells. For effective treatment, the linear energy transfer (LET) is a key parameter in ensuring the destruction of diseased cells, and both the dose and LET are typically represented as functions of depth. The distribution of dose and LET in the target depends on the beam properties, including beam energy, energy spread, beam size, and beam emittance. The aim of this work is to present the method used to characterize the proton beam properties obtained from the machine employed in the simulation and to determine the dose and dose-averaged LET (LETd) values, including their peak positions in depth. These results are used to predict the dose and LETd at different depth positions under experimental conditions. We utilized GEANT4, a Monte Carlo (MC) simulation-based software, to examine the integral depth-dose position and the peak position of the LETd. The proton source was obtained from a cyclotron accelerator, specifically the Varian ProBeam Compact spot scanning system at King Chulalongkorn Memorial Hospital in Bangkok, Thailand. The system provides proton energies ranging from 70 MeV to 220 MeV. In this study, four proton energies—70 MeV, 100 MeV, 150 MeV, and 220 MeV—were chosen to characterize the beam properties. The 80%–20% distal fall-off obtained from the simulation was used to determine the energy spread for each selected energy by matching the depth-dose peak with the measurement data. The optimal energy spreads were found to be 1.5%, 1.25%, 1%, and 0.5% for proton energies of 70 MeV, 100 MeV, 150 MeV, and 220 MeV, respectively. These energy spreads ensure that the difference in the depth-dose profile is below 1% when comparing the simulated and measured depth-dose profiles. Furthermore, the peak LETd was found to be approximately 1 mm away from the R80 position, a depth that corresponds to 80% of maximum dose, for each energy. This information can be used to guide the desired LETd position by utilizing the R80 depth position.
- 9 July 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (14) , 7670
Open AccessGEANT4 Simulation of Proton Beam Properties from a Cyclotron Accelerator at King Chulalongkorn Memorial Hospital
The main objective of proton beam therapy is to precisely irradiate diseased tissue while minimizing damage to healthy cells. For effective treatment, the linear energy transfer (LET) is a key parameter in ensuring the destruction of diseased cells, and both the dose and LET are typically represented as functions of depth. The distribution of dose and LET in the target depends on the beam properties, including beam energy, energy spread, beam size, and beam emittance. The aim of this work is to present the method used to characterize the proton beam properties obtained from the machine employed in the simulation and to determine the dose and dose-averaged LET (LETd) values, including their peak positions in depth. These results are used to predict the dose and LETd at different depth positions under experimental conditions. We utilized GEANT4, a Monte Carlo (MC) simulation-based software, to examine the integral depth-dose position and the peak position of the LETd. The proton source was obtained from a cyclotron accelerator, specifically the Varian ProBeam Compact spot scanning system at King Chulalongkorn Memorial Hospital in Bangkok, Thailand. The system provides proton energies ranging from 70 MeV to 220 MeV. In this study, four proton energies—70 MeV, 100 MeV, 150 MeV, and 220 MeV—were chosen to characterize the beam properties. The 80%–20% distal fall-off obtained from the simulation was used to determine the energy spread for each selected energy by matching the depth-dose peak with the measurement data. The optimal energy spreads were found to be 1.5%, 1.25%, 1%, and 0.5% for proton energies of 70 MeV, 100 MeV, 150 MeV, and 220 MeV, respectively. These energy spreads ensure that the difference in the depth-dose profile is below 1% when comparing the simulated and measured depth-dose profiles. Furthermore, the peak LETd was found to be approximately 1 mm away from the R80 position, a depth that corresponds to 80% of maximum dose, for each energy. This information can be used to guide the desired LETd position by utilizing the R80 depth position.